Cooling Pillow for Atopic Dermatitis

NCT ID: NCT01132651

Last Updated: 2015-01-05

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-05-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if using a cooling pillow at night will help sleep quality in people with atopic dermatitis (AD).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis Eczema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chillow cooling pillow

This group of subjects will follow their current eczema regimen with the addition of using the cooling pillow at night to sleep on.

Group Type EXPERIMENTAL

Chillow cooling pillow

Intervention Type OTHER

Subjects will use the cooling pillow to sleep on in addition to their current eczema treatment for 2 weeks.

Standard of care (regular pillow at night)

This group of subjects will serve as the control group following a their current eczema care regimen, including sleeping on their normal pillow.

Group Type PLACEBO_COMPARATOR

Current standard eczema treatment and standard pillow at night

Intervention Type OTHER

Subjects will continue with their current eczema care and use their normal pillow at night.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Current standard eczema treatment and standard pillow at night

Subjects will continue with their current eczema care and use their normal pillow at night.

Intervention Type OTHER

Chillow cooling pillow

Subjects will use the cooling pillow to sleep on in addition to their current eczema treatment for 2 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of AD by dermatologist
* AD located on the head and neck
* Investigator Global Assessment (IGA)score \>3 at time of enrollment
* Able to read, write, and understand study materials
* Age 18 or older

Exclusion Criteria

* Concurrent non-AD skin disease on the head and neck
* Active skin infection on the head and neck, or conditions that may interfere with evaluation of the skin
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dennis West

Professor in Dermatology and Pediatrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dennis West, PhD

Role: PRINCIPAL_INVESTIGATOR

Northwestern University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Northwestern University Feinberg School of Medicine, Department of Dermatology

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STU 28933

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Scratching Validation Study
NCT05137093 COMPLETED